Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chandra Prakash Prasad
Combination Therapy Targeting the Elevated Interleukin-6 Level Reduces Invasive Migration of BRAF Inhibitor-Resistant Melanoma Cells
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells
Clinical Cancer Research
Cancer Research
Oncology
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma
Cancers
Cancer Research
Oncology
Why Do We Need a New BRAF-MEK Inhibitor Combination in Melanoma?
Oncology in Clinical Practice
Oncology
Tyrphostin AG1296, a Platelet-Derived Growth Factor Receptor Inhibitor, Induces Apoptosis, And reduces Viability and Migration of PLX4032-resistant Melanoma Cells
OncoTargets and Therapy
Oncology
Pharmacology
Luteolin Reduces the Invasive Potential of Malignant Melanoma Cells by Targeting Β3 Integrin and the Epithelial-Mesenchymal Transition
Acta Pharmacologica Sinica
Medicine
Pharmacology
Ineffective Anti PD-1 Therapy After BRAF Inhibitor Failure in Advanced Melanoma
BMC Cancer
Cancer Research
Oncology
Genetics
Combination Therapy With BRAF and MEK Inhibitors for Melanoma: Latest Evidence and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
Combination of Amino Acids Reduces Pigmentation in B16F0 Melanoma Cells
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
